// App-Quantinova.ai

196 : Clinical performance of Immunoscore in stage III colorectal cancer patients in the SCOT and IDEA-HORG cohorts.

Researchers

Presenter

  • David Church

Principal Investigators

  • Noori Maka

  • Joanne Edwards

  • Karin Oien

  • Timothy Iveson

  • Mark P. Saunders

  • Ioannis Boukovinas

  • Ippokratis Messaritakis

  • Eleni Moustou

  • Maria Chondrozoumaki

  • Vassilis Georgoulias

  • Alboukadel Kassambara

  • Aurelie Catteau

  • Jerome Galon

  • Laura Dempsey

  • Jennifer Hay

  • Caroline Kelly

  • Ioannis Sougklakos

  • Andrea Harkin

Medical Centers

  • Wellcome Centre for Human Genetics & Oxford Cancer Centre, University of Oxford Roosevelt Drive, Oxford, United Kingdom

  • The Beatson Institute for Cancer Research, Glasgow, United Kingdom

  • NHS Greater Glasgow & Clyde, Glasgow, United Kingdom

  • University of Glasgow, Glasgow, United Kingdom

  • Institute of Cancer Science, University of Glasgow, Glasgow, United Kingdom

  • University Hospital Southampton NHS Foundation Trust, Southampton, United Kingdom

  • The Christie NHS Foundation TRUST, Manchester, United Kingdom

  • Bioclinic Thessaloniki Medical Oncology Unit, Thessaloniki, Greece

  • Laboratory of Tumor Cell Biology, School of Medicine, University of Crete, Heraklion, Greece

  • Laboratory of Pathology, University General Hospital of Heraklion, Heraklion, Greece

  • Lab of Translational Oncology Medical School University of Crete, Heraklion, Greece

  • Laboratory of Tumor Cell Biology, School of Medicine, University of Crete, Heraklion, Greece

  • Veracyte, Marseille, France

  • HalioDx, Marseille, France

  • Cancer Research UK Clinical Trials Unit, Institute of Cancer Research, University of Glasgow, Glasgow, United Kingdom

  • Cancer Research UK Glasgow Clinical Trials Unit, Glasgow, United Kingdom

  • Glasgow, United Kingdom

Locations

  • United Kingdom

  • Greece

  • France

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Colorectal Cancer

Biomarkers

  • 3-Oxoacid CoA-Transferase 1

  • Immunoscore

Drug/Treatment

  • mFOLFOX6

  • Capecitabine + Oxaliplatin

Outcome

  • N/A

Study Design

  • N/A

Phase

  • N/A

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved